PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program
Abstract
Authors
A.D. Morais M.L. Pereira H. Azevedo